4.7 Article

Novel high/low solubility classification methods for new molecular entities

期刊

INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 511, 期 1, 页码 111-126

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2016.06.060

关键词

Solubility; High throughput technologies; Analytical chemistry; Computational ADME; In silico modeling; Computer aided drug design; ROC curve analysis

资金

  1. National Institutes of Health National Institute on Drug Abuse [R01DA023223]

向作者/读者索取更多资源

This research describes a rapid solubility classification approach that could be used in the discovery and development of new molecular entities. Compounds (N = 635) were divided into two groups based on information available in the literature: high solubility (BDDCS/BCS 1/3) and low solubility (BDDCS/BCS 2/4). We established decision rules for determining solubility classes using measured log solubility in molar units (MLogS(M)) or measured solubility (MSol) in mg/ml units. ROC curve analysis was applied to determine statistically significant threshold values of MSol and MLogS(M). Results indicated that NMEs with MLogS(M) > -3.05 or MSol > 0.30 mg/mL will have >= 85% probability of being highly soluble and new molecular entities with MLogS(M) < -3.05 or MSol < 0.30 mg/mL will have >85% probability of being poorly soluble. When comparing solubility classification using the threshold values of MLogS(M) or MSol with BDDCS, we were able to correctly classify 85% of compounds. We also evaluated solubility classification of an independent set of 108 orally administered drugs using MSol (0.3 mg/mL) and our method correctly classified 81% and 95% of compounds into high and low solubility classes, respectively. The high/low solubility classification using MLogS(M) or MSol is novel and independent of traditionally used dose number criteria. (C) 2016 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据